Efficiency of the Imaging Strategy for the Management of Suspected Covid-19

Emergency departments have been placed at the heart of the patient triage strategy during the COVID-19 epidemic. In the absence of scientific knowledge on the most efficient strategy to put in place in emergency structures, the centers have proposed very heterogeneous protocols resulting from collaboration with local radiology and virology teams. While the pandemic in France appears to be currently under control, it is important to assess the sorting strategies put in place to deal with a new epidemic.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Confusion Coronaviridae Infections Coronavirus Infections Cough Diarrhea Dyspnea Infections Lung Diseases Nervous System Diseases Neurobehavioral Manifestations Neurologic Manifestations Nidovirales Infections Pathological Conditions, Signs and Symptoms Pneumonia Pneumonia, Viral RNA Virus Infections Respiration Disorders Respiratory Tract Diseases Respiratory Tract Infections Signs and Symptoms Signs and Symptoms, Digestive Signs and Symptoms, Respiratory Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Service d'accueil des urgences - Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Major subject (≥18 years old)
Subject treated in the emergency rooms of participating centers for suspicion of COVID-19 presenting with fever> 38 ° and / or respiratory signs (dyspnea, cough, sputum) and / or other symptoms suggestive of COVID-19 (diarrhea , confusion ...) and / or people over 85 or living in an institution during the study period from March 9 to May 8, 2020
Subject affiliated to a social health insurance protection scheme
Subject not having expressed their opposition, after information, to the reuse of their data for the purposes of this research

Exclusion criteria

Subject having expressed opposition to participating in the study
Subject under guardianship or guardianship
Subject under safeguard of justice

Treatment and study plan

Primary outcomes

A retrospective study of the imaging strategy for the management of suspected Covid-19

Time frame: Files analysed retrospectively from March 09, 2020 to May 08, 2020 will be examined]

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Acronym: EFFI-COVID-19

Important dates

Study start: 2020
Primary completion: 2021
Study completion: 2021
First posted: Oct 14, 2021
Registry last updated: Nov 15, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed